Sahm Adrangi is somewhat of an anomaly amongst his peers on Wall Street, utilizing his unique skill to do what few before him have done, expose and take a down a myriad of fraudulent foreign companies. Sahm Adrangi has made a name for himself throughout the industry by doing this, as well as for publishing research that illustrates his, as well as his firm, Kerrisdale Capital Management’s, viewpoints regarding stocks. The goal of Mr. Adrangi’s research is to help the masses understand the true prospects of a rising company, often combating commonly held misconceptions regarding their futures. Mr. Adrangi has separated himself from his peers regarding the way in which he delivers his research perspectives by utilizing social media outlets such as Twitter, while also taking advantage of his own platform and other third-party sites that specialize in investing. Recently, Sahm Adrangi has placed significant emphasis on biotechnology, as it is one of the fastest growing industries around the world. In 2017, Mr. Adrangi and Kerrisdale Capital Management released research on two major biotech companies, Sage and Bavarian Nordic, which proved to be correct in exposing the impending failure of a prospective cancer vaccine.
After his recent success, Sahm Adrangi has decided to focus on another biotech company, Prothena, which according to his firm, has failed to capitalize on early tests, suggesting a devastating loss for the company, as well as its stockholders. Since starting Kerrisdale Capital Management, which was founded on less than one million U.S., he has raised the assets to well over $100 million. Recently, in an effort to short a new, unnamed stock, Mr. Adrangi was able to raise an additional $100 million to be focused solely on that stock. This move is being referred to as a co-investment, which according to sources, is the first of its kind. The amount of capital that Mr. Adrangi and Kerrisdale Capital Management have been able to raise in such a short period of time, has essentially shaken the community, causing an unprecedented amount of focus to be geared at it, and learn more about Sahm Adrangi.